Viewing Study NCT04921358


Ignite Creation Date: 2025-12-25 @ 12:20 AM
Ignite Modification Date: 2025-12-25 @ 10:24 PM
Study NCT ID: NCT04921358
Status: TERMINATED
Last Update Posted: 2025-06-29
First Post: 2021-05-25
Is NOT Gene Therapy: False
Has Adverse Events: True

Brief Title: Tislelizumab in Combination With Sitravatinib in Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Sponsor:
Organization: